Inflammatory mechanisms in Alzheimer's disease: implications for therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (85)
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
1984 • 5,166 citations
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
1987 • 4,544 citations
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
1985 • 4,276 citations
Lysosomotropic agents
1974 • 1,887 citations
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
1990 • 1,388 citations
Goodman and Gilman's The Pharmacological Basis of Therapeutics
1991 • 1,330 citations
Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging
1985 • 1,129 citations
Clinical trial of indomethacin in Alzheimer's disease
1993 • 996 citations
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
1989 • 904 citations
Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
1988 • 899 citations
Interleukin 1 of the central nervous system is produced by ameboid microglia.
1986 • 858 citations
Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
1989 • 856 citations
Complement activation by beta-amyloid in Alzheimer disease.
1992 • 804 citations
Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives
1992 • 737 citations
Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
1988 • 702 citations
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
1989 • 692 citations
Colchicine in the Prevention and Treatment of the Amyloidosis of Familial Mediterranean Fever
1986 • 667 citations
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
1992 • 618 citations
Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.
1990 • 604 citations
Textbook of Rheumatology.
1988 • 593 citations
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
1991 • 489 citations
Hippocampal Aging and Adrenocorticoids: Quantitative Correlations
1978 • 486 citations
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
1991 • 484 citations
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.
1987 • 475 citations
The Stress Response and the Regulation of Inflammatory Disease
1992 • 469 citations
A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults
1985 • 406 citations
The Amino Acid Sequence of a Major Nonimmunoglobulin Component of Some Amyloid Fibrils
1972 • 397 citations
Arthritis and Allied Conditions
1985 • 374 citations
Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
1990 • 373 citations
<scp>D</scp>-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma)
1982 • 317 citations
Cytokines as modulators of the hypothalamus-pituitary-adrenal axis
1991 • 289 citations
Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain
1989 • 281 citations
Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion
1991 • 276 citations
Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?
1991 • 267 citations
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes
1988 • 263 citations
IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID
1973 • 236 citations
Use of short‐term efficacy/toxicity tradeoffs to select second‐line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials
1992 • 232 citations
Adrenal glucocorticoids after twenty years
1970 • 209 citations
Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein.
1992 • 202 citations
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE 12
1948 • 180 citations
Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease
1990 • 174 citations
Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4'-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane.
1980 • 169 citations
Immunosuppressive potential of antimalarials
1983 • 158 citations
α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsin
1990 • 153 citations
α1‐Antichymotrypsin as a possible biochemical marker for Alzheimer‐type dementia
1990 • 147 citations
The disordered neuronal cytoskeleton in Alzheimer's disease
1992 • 124 citations
Cognitive dysfunction associated with naproxen and ibuprofen in the elderly
1982 • 123 citations
Chloroquine Diphosphate in Rheumatoid Arthritis : A Controlled Trial
1961 • 122 citations
Glucocorticoids and hippocampal damage
1987 • 120 citations
Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment.
1991 • 105 citations
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert
1991 • 105 citations
Cytokines and inflammation
1992 • 101 citations
The participation of interleukin-6 in the pathogenesis of alzheimer's disease
1992 • 100 citations
Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease
1990 • 99 citations
Central and Peripheral Endorphins: Basic and Clinical Aspects
1986 • 89 citations
Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease
1992 • 81 citations
Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid
1989 • 79 citations
Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage.
1975 • 79 citations
Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis
1962 • 78 citations
Colchicine
1974 • 69 citations
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
1987 • 61 citations
The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia
1990 • 61 citations
Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin I
1990 • 55 citations
Plasma and cerebrospinal fluid concentrations of indomethacin in humans
1990 • 54 citations
The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2.
1991 • 51 citations
Serum Amyloid P in Alzheimer's Disease
1991 • 51 citations
Ocular Safety of Hydroxychloroquine Sulfate (Plaquenil)
1992 • 48 citations
Cytokines and inflammatory proteins in alzheimer's disease
1992 • 47 citations
Developmental expression of α1-antichymotrypsin in brain may be related to astrogliosis
1991 • 46 citations
Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in alzheimer's disease
1992 • 44 citations
The role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injury
1992 • 40 citations
Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease
1992 • 39 citations
Distribution of Radioactive Colchicine in Some Organs of Normal and Tumor-bearing Mice.
1951 • 37 citations
ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE EFFECTS OF RECOMBINANT SOLUBLE COMPLEMENT RECEPTORS
1991 • 37 citations
Serological α1‐Antichymotrypsin in Down's syndrome and Alzheimer's disease
1992 • 37 citations
PLAQUENIL IN THE TREATMENT OF LUPUS ERYTHEMATOSUS
1956 • 37 citations
Anatomic, Metabolic, Neuropsychological, and Molecular Genetic Studies of Three Pairs of Identical Twins Discordant for Dementia of the Alzheimer's Type
1991 • 37 citations
Role of Microtubuli in the Lysosomal Degradation of Endogenous and Exogenous Protein in Isolated Rat Hepatocytes
1981 • 31 citations
Monozygotic twins discordant for Alzheimer's disease
1989 • 28 citations
Hydroxychloroquine sulfate in rheumatoid arthritis: Long-term response rate and predictive parameters
1983 • 25 citations
Complements, microglial cells and amyloid fibril formation
1992 • 25 citations
Inhibition of interleukin-1 release by IX 207-887
1990 • 18 citations
Toxic and Metabolic Encephalopathies in Long-Term Care Patients
1991 • 16 citations
Combined Administration of Physcostigmine and Clonidine to Paients with Dementia of the Alzheimer Type
1989 • 13 citations
A hypothesis concerning the role of endogenous colchicine-like factors in the etiology of Alzheimer's disease
1987 • 7 citations